A new parenteral cephalosporin, cephanone, was studied in vitro.
The study reported here had a threefold purpose: provision of additional data regarding the in vitro activity of cephanone against recently isolated pathogenic bacteria; assessment of the degree of correlation between susceptibility data obtained by using were inhibited by 32 lAg of cephanone per ml.
Again, Enterobacter species were more resistant, with only 24% being susceptible to 32 ,ug/ml. MIC values for gram-positive organisms we're similar to the broth dilution values ( Table  3) .
The results of the disk tests performed in parallel with the agar dilution studies were similar to those obtained in the broth dilution studies (Tables 4 and 5 ). The major difference was seen with enterococci, but the overall pattern of results was not altered. Correlation and regression analyses of data from the agar dilution and cephanone disk studies yielded significant statistics (P < 0.01) for all organisms except Klebsiella, P. mirabilis, and ,B-hemolytic streptococci. Statistics similar to the above were obtained when data from the cephanone agar dilution and cephalothin disk experiments were analyzed.
These results are in general agreement with two previously published reports (5, 8) . Data regarding achievable serum levels for cephanone in man (6) 
